Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease.
Alzheimer's disease (AD), an incurable, progressive neurodegenerative disorder, is the most common form of dementia. Therapeutic options have been elusive due to the inability to deliver proteins across the blood-brain barrier (BBB). In order to improve the therapeutic potential for AD, we util...
Main Authors: | Brian Spencer, Robert A Marr, Ryan Gindi, Rewati Potkar, Sarah Michael, Anthony Adame, Edward Rockenstein, Inder M Verma, Eliezer Masliah |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3031588?pdf=render |
Similar Items
-
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
by: Patrick Christina, et al.
Published: (2008-11-01) -
Increased BACE1 activity inhibits peripheral nerve regeneration after injury
by: Carolyn Tallon, et al.
Published: (2017-10-01) -
Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease
by: Brian Spencer, et al.
Published: (2019-07-01) -
Immunotherapy for Alzheimer’s Disease: Past, Present and Future
by: Brian eSpencer, et al.
Published: (2014-06-01) -
Molecular Pathology of Neuro-AIDS (CNS-HIV)
by: Eliezer Masliah, et al.
Published: (2009-03-01)